ShareHope Medicine Co., Ltd.

8403

TW0008403007

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
31.55 ^TWD	+0.80%		+1.45%	-4.10%

Mar. 20	ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

ShareHope Medicine Co., Ltd. Announces Change in Members of the Audit Committee of the Company

July 30, 2021 at 07:50 am EDT

ShareHope Medicine Co., Ltd. announced name and resume of the previous position holder: (1) Yu-Fen, Lin/Lawyer in Charge of Fa-Yu United Law Firm; (2) Gang-Zhai Wu/partner accountant of Zhang-Yu United CPA firm. Name and resume of the new position holder: (1) Gang-Zhai Wu/partner accountant of Zhang-Yu United CPA firm; (3) Ho-ming Chen/Professor of International Business, National Taiwan University. Date of occurrence of the change is July 30, 2021.

Latest news about ShareHope Medicine Co., Ltd.

ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 12	CI
ShareHope Medicine Co., Ltd.(TPEX:8403) added to S&P Global BMI Index	23-09-18	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
ShareHope Medicine Co., Ltd. Announces Cash Dividend, Payable on October 3, 2023	23-08-11	CI
ShareHope Medicine Co., Ltd. Announces Election of Yao Xiubi as Members of the Audit Committee	23-06-30	CI
ShareHope Medicine Co., Ltd. Elects Board of Directors	23-06-30	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-11	CI
ShareHope Medicine Co., Ltd. Announces Cash Dividend, Payable on October 4, 2022	22-08-12	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-15	CI
Sharehope Medicine Co., Ltd. Announces Cash Dividend for the Year 2021	22-05-13	CI
ShareHope Medicine Co., Ltd. announced that it expects to receive TWD 57.16293 million in funding	22-05-12	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Sharehope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-10	CI
ShareHope Medicine Co., Ltd. Announces Change in Members of Remuneration Committee	21-08-06	CI
ShareHope Medicine Co., Ltd. Announces Change in Members of the Audit Committee of the Company	21-07-30	CI
Sharehope Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Sharehope Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Sharehope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-11	CI
ShareHope Medicine Co., Ltd. Announces Appointment of Hsu Sheng-Shen as Vice Chairman	20-11-06	CI
Sharehope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-13	CI

Chart ShareHope Medicine Co., Ltd.

Duration

Period

More charts

Company Profile

ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
SHAREHOPE MEDICINE CO., LTD.	-4.10%	121M
MCKESSON CORPORATION	+16.62%	70.36B
CARDINAL HEALTH, INC.	+2.99%	25.18B
SINOPHARM GROUP CO. LTD.	+6.36%	8.61B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.46%	8.14B
HUADONG MEDICINE CO., LTD	-21.01%	7.83B
H. LUNDBECK A/S	-0.61%	4.56B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	-0.14%	4.06B
GALENICA AG	-3.30%	3.87B